Relay Therapeutics (RLAY) Leases (2020 - 2025)
Historic Leases for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to $41.4 million.
- Relay Therapeutics' Leases fell 2246.75% to $41.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.4 million, marking a year-over-year decrease of 2246.75%. This contributed to the annual value of $51.8 million for FY2024, which is 1070.74% down from last year.
- According to the latest figures from Q3 2025, Relay Therapeutics' Leases is $41.4 million, which was down 2246.75% from $42.7 million recorded in Q2 2025.
- Over the past 5 years, Relay Therapeutics' Leases peaked at $65.2 million during Q3 2022, and registered a low of $19.8 million during Q2 2022.
- For the 5-year period, Relay Therapeutics' Leases averaged around $45.8 million, with its median value being $52.6 million (2024).
- In the last 5 years, Relay Therapeutics' Leases surged by 20719.69% in 2023 and then tumbled by 2246.75% in 2025.
- Quarter analysis of 5 years shows Relay Therapeutics' Leases stood at $20.8 million in 2021, then soared by 206.8% to $63.8 million in 2022, then dropped by 9.07% to $58.0 million in 2023, then fell by 10.71% to $51.8 million in 2024, then dropped by 20.08% to $41.4 million in 2025.
- Its Leases was $41.4 million in Q3 2025, compared to $42.7 million in Q2 2025 and $50.1 million in Q1 2025.